Kairos Pharma, Ltd. KAPA
1.72
(0.05)
(2.82%)
as of 25 Sep
- Market cap
- $6.1M
- P/E
- 0.0×
Follow KAPA
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Current Ratio |
27.07 | 4.20 | 0.04 | 0.27 |
Net Debt/EBITDA |
1.65 | 2.04 | (0.37) | (49.67) |
Debt/Assets |
0.00% | 0.00% | 66.53% | 56.56% |
Debt/Equity |
0.00 | 0.00 | (0.31) | (0.50) |
Asset Turnover |
0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.63 | 1.52 | (0.04) | 0.34 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| (97.99%) | (192.96%) | 111.27% | 0.00% | |
| (88.51%) | (77.32%) | (181.11%) | 0.00% | |
ROIC |
(346.52%) | (227.03%) | 0.00% | 0.00% |
Return on Tangible Assets |
(104.99%) | (81.93%) | 78.65% | 87.79% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.01 | 0.04 | 0.40 | 0.52 |
Share Based Compensation of Revenue |
— | 0.00% | — | — |
Free Cash Flow per Share |
(1.31) | (2.44) | 0.05 | (0.23) |
Cash per Share |
2.03 | 2.55 | 0.06 | 0.28 |
Shareholders Equity per Share |
2.41 | 2.94 | (1.40) | (0.76) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.41 | 2.94 | (1.40) | (0.76) |
Free Cash Flow |
(3.44) | (3.95) | 0.08 | (0.35) |
Working Capital |
5.19 | 3.18 | (2.30) | (1.20) |
Net Current Asset Value |
5.19 | 3.18 | (2.94) | (1.78) |
| Other line items | ||||
Quick Ratio |
26.81 | 4.16 | 0.04 | 0.27 |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(29.47%) | (44.40%) | (6.03%) | 226.28% |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(1.31) | (2.44) | 0.05 | (0.23) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
0.60 | 1.70 | 2.02 | — |
Average Assets |
6.15 | 3.37 | 1.00 | — |
Average Common Equity |
5.56 | 1.35 | (1.63) | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates